Market Tracker

02/24 5:16pm ET

Cynosure Inc (NASDAQ:CYNO)

66.30
Delayed Data
As of Feb 24
 +0.05 / +0.08%
Today’s Change
37.64
Today|||52-Week Range
66.65
+45.39%
Year-to-Date
Medtronic Earnings Rebound in Third Quarter, Shares Climb
Feb 21 / TheStreet.com - Paid Partner Content
Why Cynosure, RetailMeNot, and TransUnion Jumped Today
Feb 14 / MotleyFool.com - Paid Partner Content
Cynosure (CYNO) to be Acquired by Hologic in $1.65B Deal
Feb 15 / Zacks.com - Paid Partner Content
Here's Why Cynosure, Inc. is Soaring Today
Feb 14 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close66.25
Today’s open66.25
Day’s range66.20 - 66.40
Volume1,054,114
Average volume (3 months)834,231
Market cap$1.6B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-7.14%
Earnings growth (this year)+20.57%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+27.71%
P/E ratio74.5
Price/Sales2.49
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SPNCSpectranetics Corp+1.50+5.65%
IRTCIrhythm Technologies...-0.12-0.30%
LIVNLivaNova PLC+0.35+0.72%
NVRONevro Corp+4.72+5.01%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$433.5M
Annual profit (last year)$15.4M
Net profit margin3.56%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Davin
CFO, Chief Accounting Officer, Treasurer &
EVP
Stephen J. Webber
Corporate headquarters
Westford, Massachusetts

Forecasts